SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )
Spectrum Pharmaceuticals Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
84763A108
--------------------------------------------------------------------------------
(CUSIP Number)
May 13, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 84763A108 13G Page 2 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Partners, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 255,320
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 255,320
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
255,320
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.2%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 84763A108 13G Page 3 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Offshore Fund, Ltd.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 42,553
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 42,553
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
42,553
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.4%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 84763A108 13G Page 4 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Management, L.L.C.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 42,553
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 42,553
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
42,553
(Reporting person disclaims beneficial ownership of shares held by ProMed
Offshore Fund, Ltd. which represent the interests of shareholders of ProMed
Offshore Fund, Ltd.).
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.4%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IA
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 84763A108 13G Page 5 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ProMed Asset Management, L.L.C.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 255,320
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 255,320
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
255,320
(Reporting person disclaims beneficial ownership of shares held by ProMed
Partners, L.P. which represent the interests of other partners of ProMed
Partners, L.P.)
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.2%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IA
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 84763A108 13G Page 6 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
David B. Musket
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 297,873
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 297,873
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
297,873
(Reporting person disclaims beneficial ownership of shares held by ProMed
Partners, L.P. and ProMed Offshore Fund, Ltd. which represent the interests of
such entities' other partners and shareholders, respectively.)
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.6%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 84763A108 13G Page 7 of 12 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Barry Kurokawa
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 20,000
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 297,873
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 20,000
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 297,873
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
317,873
(Reporting person disclaims beneficial ownership of shares held by ProMed
Partners, L.P. and ProMed Offshore Fund, Ltd. which represent the interests of
these entities' other partners and shareholders, respectively.)
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.2%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 8 of 12 Pages
Item 1(a). Name of Issuer:
Spectrum Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
Item 1(b). Address of Issuer's Principal Executive Offices:
157 Technology Drive, Irvine, CA, 92618
--------------------------------------------------------------------------------
Item 2(a). Name of Person Filing:
ProMed Partners, L.P., ProMed Offshore Fund, Ltd., ProMed Management, L.L.C.,
ProMed Asset Management, L.L.C., David B. Musket and Barry Kurokawa
--------------------------------------------------------------------------------
Item 2(b). Address of Principal Business Office, or if None, Residence:
125 Cambridgepark Drive, Cambridge, MA 02140
--------------------------------------------------------------------------------
Item 2(c). Citizenship:
See pages 2,3,4,5,6 and 7
--------------------------------------------------------------------------------
Item 2(d). Title of Class of Securities:
Common Stock
--------------------------------------------------------------------------------
Item 2(e). CUSIP Number:
84763A108
--------------------------------------------------------------------------------
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box [X]
Page 9 of 12 Pages
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
See pages 2,3,4,5,6 and 7
(b) Percent of class:
See pages 2,3,4,5,6 and 7
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
See pages 2,3,4,5,6 and 7
(ii) Shared power to vote or to direct the vote
See pages 2,3,4,5,6 and 7
(iii) Sole power to dispose or to direct the disposition of
See pages 2,3,4,5,6 and 7
(iv) Shared power to dispose or to direct the disposition of
See pages 2,3,4,5,6 and 7
--------------------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
--------------------------------------------------------------------------------
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not Applicable
--------------------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not Applicable
--------------------------------------------------------------------------------
Item 8. Identification and Classification of Members of the Group.
See "Exhibit A" attached hereto and pages 2, 3, 4, 5, 6 and 7
--------------------------------------------------------------------------------
Item 9. Notice of Dissolution of Group.
Not Applicable
--------------------------------------------------------------------------------
Item 10. Certifications.
(a) The following certification shall be included if the statement is
filed pursuant to Rule 13d-1(b):
"By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and not held for
the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having such purpose or effect."
(b) The following certification shall be included if the statement is
filed pursuant to Rule 13d-1(c):
"By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having such purpose or effect."
Page 10 of 12 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
June 6, 2003
----------------------------------------
(Date)
/s/ David B. Musket
----------------------------------------
(Signature)
David B. Musket,
President of Managing Member
of the General Partner
----------------------------------------
(Name/Title)
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
Schedule 13 G Page 11 of 12
CUSIP No. 84763A108
Index to Exhibits
Exhibit Page No.
------- --------
Exhibit A -- Joint Filing Agreement, dated June 6, 2003 12
Schedule 13 G Page 12 of 12
CUSIP No. 84763A108
EXHIBIT A
JOINT FILING AGREEMENT
ProMed Partners, L.P., ProMed Offshore Fund, Ltd., ProMed Management,
L.L.C., ProMed Asset Management, L.L.C., David B. Musket and Barry Kurokawa each
hereby agrees that the Schedule 13G to which this Exhibit is attached and any
amendments thereto relating to the acquisition of shares of Common Stock of
Spectrum Pharmaceuticals Inc. is filed jointly on behalf of each such person.
Dated: June 6, 2003
/s/ David B. Musket
------------------------------------------
David B. Musket
/s/ Barry Kurokawa
Barry Kurokawa
PROMED PARTNERS, L.P.
By: ProMed Asset Management, L.L.C.
its General Partner
By: DBM Corporate Consulting Group, Ltd.
a Managing Member
By: /s/ David B. Musket
-------------------------------------
Name: David B. Musket
Title: President
PROMED OFFSHORE FUND, LTD.
By: /s/ David B. Musket
-------------------------------------
Name: David B. Musket
Title: Director
PROMED MANAGEMENT, L.L.C.
By: DBM Corporate Consulting Group, Ltd.
a Managing Member
By: /s/ David B. Musket
-------------------------------------
Name: David B. Musket
Title: President
PROMED ASSET MANAGEMENT, L.L.C.
By: DBM Corporate Consulting Group, Ltd.
A Managing Member
By: /s/ David B. Musket
-------------------------------------
Name: David B. Musket
Title: President